DE69418183D1 - Immunotherapeutische zubereitung - Google Patents

Immunotherapeutische zubereitung

Info

Publication number
DE69418183D1
DE69418183D1 DE69418183T DE69418183T DE69418183D1 DE 69418183 D1 DE69418183 D1 DE 69418183D1 DE 69418183 T DE69418183 T DE 69418183T DE 69418183 T DE69418183 T DE 69418183T DE 69418183 D1 DE69418183 D1 DE 69418183D1
Authority
DE
Germany
Prior art keywords
present
preparation
immunotherapeutic preparation
immunotherapeutic
abort
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69418183T
Other languages
English (en)
Other versions
DE69418183T2 (de
Inventor
Stanley J Alkemade
Graeme Mcrae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vetrepharm Inc
Original Assignee
Vetrepharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetrepharm Inc filed Critical Vetrepharm Inc
Publication of DE69418183D1 publication Critical patent/DE69418183D1/de
Application granted granted Critical
Publication of DE69418183T2 publication Critical patent/DE69418183T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69418183T 1993-01-29 1994-01-28 Immunotherapeutische zubereitung Expired - Lifetime DE69418183T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1165593A 1993-01-29 1993-01-29
PCT/CA1994/000054 WO1994016727A1 (en) 1993-01-29 1994-01-28 Immunotherapeutic composition

Publications (2)

Publication Number Publication Date
DE69418183D1 true DE69418183D1 (de) 1999-06-02
DE69418183T2 DE69418183T2 (de) 1999-12-16

Family

ID=21751403

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69418183T Expired - Lifetime DE69418183T2 (de) 1993-01-29 1994-01-28 Immunotherapeutische zubereitung

Country Status (11)

Country Link
US (1) US5759554A (de)
EP (1) EP0681479B1 (de)
JP (1) JPH08508976A (de)
CN (1) CN1102855C (de)
AT (1) ATE179333T1 (de)
AU (1) AU691797B2 (de)
BR (1) BR9406496A (de)
DE (1) DE69418183T2 (de)
DK (1) DK0681479T3 (de)
NZ (1) NZ261094A (de)
WO (1) WO1994016727A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
CN1153574C (zh) * 1997-04-02 2004-06-16 比奥尼斯生命科学公司 细菌细胞壁提取物在制备预防,治疗或排除原生动物或寄生虫疾病的药物组合物上的应用
AU736450B2 (en) 1997-08-05 2001-07-26 Bioniche Urology Ip Inc. Composition and method for regulating cell proliferation and cell death
US6809081B1 (en) * 1998-12-04 2004-10-26 Bioniche Life Sciences, Inc. Chemotherapeutic composition and method
ATE273027T1 (de) * 1998-12-04 2004-08-15 Bioniche Life Sciences Inc Zusammensetzung zur behandlung von entzündungen
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
WO2001007080A2 (en) * 1999-07-23 2001-02-01 Bioniche Life Sciences Inc. Method for enhancing production performance in an animal
US6890541B1 (en) 1999-07-23 2005-05-10 Bioniche Life Sciences, Inc. Method for enhancing production performance in an animal
JP4772245B2 (ja) * 1999-12-13 2011-09-14 バイオニケ ライフ サイエンシーズ インコーポレイテッド 治療上有用な合成オリゴヌクレオチド
AU784356B2 (en) 1999-12-28 2006-03-16 Bioniche Urology Ip Inc. Hyaluronic acid in the treatment of cancer
AU8729101A (en) * 2000-03-31 2001-10-15 Idec Pharma Corp Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for the treatment of B cell lymphoma
JP5578390B2 (ja) * 2007-03-05 2014-08-27 株式会社 Ｍｂｒ 細菌細胞壁骨格成分の製造方法
AR083443A1 (es) * 2010-10-13 2013-02-27 Bioniche Life Sciences Inc Una composicion que comprende arn bacteriano y paredes celulares bacterianas, metodo para elaborar dicha composicion y sus usos
TR201101874A2 (tr) 2011-02-25 2011-08-22 Leyla A�An Nac�Ye Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.
CA2947358A1 (en) * 2014-02-18 2015-08-27 Advaxis, Inc. Biomarker directed multi-target immunotherapy
US20200061130A1 (en) * 2016-02-25 2020-02-27 Thomas Julius Borody Compositions and methods of treatment of chronic infectious diseases
IT202000002641A1 (it) 2020-02-11 2021-08-11 Altergon Sa Composizioni antivirali
IT202000002866A1 (it) 2020-02-13 2021-08-13 Altergon Sa Composizioni antivirali
CN113244384A (zh) 2020-02-11 2021-08-13 阿尔特刚股份有限公司 抗病毒组合物
IT202100013292A1 (it) * 2021-05-21 2022-11-21 Aileens Pharma S R L Parete cellulare batterica legata a mucopolisaccaride suoi utilizzi e processo per la sua produzione

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
US3331741A (en) * 1964-12-03 1967-07-18 Warner Lambert Pharmaceutical Process for the preparation of a soluble bacterial extract
FR2160326B1 (de) * 1971-11-19 1975-02-07 Anvar
NL7308450A (de) * 1972-06-20 1973-12-27
US4069314A (en) * 1973-02-23 1978-01-17 Christopher Adlam Glycopeptide extract
CH602920A5 (de) * 1973-02-23 1978-08-15 Wellcome Found
FR2269961B1 (de) * 1974-05-06 1978-03-24 Anvar
FR2320107A1 (fr) * 1975-08-05 1977-03-04 Anvar Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
US4340586A (en) * 1977-02-18 1982-07-20 Adam Bekierkunst Pharmaceutical preparation for treating disorders of the skin
US4504473A (en) * 1982-06-30 1985-03-12 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4503048A (en) * 1982-06-30 1985-03-05 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4505903A (en) * 1982-06-30 1985-03-19 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
FR2551758B1 (fr) * 1983-08-16 1986-01-31 Anvar Derives de muramyl-peptides et de steroides ayant des proprietes d'activation des macrophages
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
WO1992008488A1 (en) * 1990-11-08 1992-05-29 University College London Mycobacterium as adjuvant for antigens
FR2662942B1 (fr) * 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.

Also Published As

Publication number Publication date
NZ261094A (en) 1998-04-27
CN1118574A (zh) 1996-03-13
BR9406496A (pt) 1996-01-02
WO1994016727A1 (en) 1994-08-04
AU691797B2 (en) 1998-05-28
JPH08508976A (ja) 1996-09-24
US5759554A (en) 1998-06-02
EP0681479B1 (de) 1999-04-28
CN1102855C (zh) 2003-03-12
DE69418183T2 (de) 1999-12-16
ATE179333T1 (de) 1999-05-15
AU5968094A (en) 1994-08-15
DK0681479T3 (da) 1999-11-08
EP0681479A1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
ATE179333T1 (de) Immunotherapeutische zubereitung
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
ATE73347T1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
DK0627933T3 (da) Bystander-suppression af autoimmune sygdomme
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
DE60236318D1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
KR890700353A (ko) 면역독소의 면역억제 기저 사람치료법
WO1999024077A3 (en) Compositions and methods for targeted delivery of biologically-active factors
PT600396E (pt) Vacinas contra protozoarios intestinais
DE50014268D1 (de) Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
CA2154689A1 (en) Improved immunotherapeutic composition
DE3373978D1 (en) Composition for the care or treatment of the human skin
SE8200748L (sv) Terapeutiskt medel
SE8303729L (sv) Terapeutiskt medel for behandling av allergiska sjukdomstillstand, immunkomplexsjukdomar och tumorer
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
DE69427533D1 (de) Ein extrakt aus muscheln, extraktionsmethoden und verwendungen davon
RU96123906A (ru) Способ и вакцина для профилактики и лечения иммунодефицитов, например рака
IT7828549A0 (it) Composizione terapeutica per il trattamento di infezioni e malattie di animali da allevamento.
BG97498U (bg) Средство за лечение на хемороиди и кожни заболявания
RU95111615A (ru) Способ лечения органа или системы с низким уровнем ответной реакции на раздражители при умеренном или высоком уровне врожденной реакции организма в целом
BG51699A1 (en) Stimulating fertility agent
ES489956A0 (es) Sistema para la aplicacion de tratamientos bronceadores y terapeuticos integrales del cuerpo humano
RU93051046A (ru) Способ борьбы с аскосферозом и гнильцовыми болезнями пчел

Legal Events

Date Code Title Description
8364 No opposition during term of opposition